Diversity of Retinal Vascular Anomalies in Patients with Familial Exudative Vitreoretinopathy

To describe the diversity of clinical findings associated with familial exudative vitreoretinopathy (FEVR) using wide-field angiography and to update the current classification system. Retrospective case series at a single tertiary referral vitreoretinal practice. A total of 174 eyes of 87 subjects...

Full description

Saved in:
Bibliographic Details
Published inOphthalmology (Rochester, Minn.) Vol. 121; no. 11; pp. 2220 - 2227
Main Authors Kashani, Amir H., Brown, Kevin T., Chang, Emmanuel, Drenser, Kimberly A., Capone, Antonio, Trese, Michael T.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.11.2014
Subjects
Online AccessGet full text

Cover

Loading…
Abstract To describe the diversity of clinical findings associated with familial exudative vitreoretinopathy (FEVR) using wide-field angiography and to update the current classification system. Retrospective case series at a single tertiary referral vitreoretinal practice. A total of 174 eyes of 87 subjects were studied. A retrospective chart review was conducted of patients with a diagnosis of FEVR between January 2011 and January 2013 at a single tertiary care retina practice. Data were collected from patient charts, including sex, gestational age at birth, age at presentation, referring diagnosis, family history, prior ocular surgery, clinical presentation, and diagnostic imaging in each eye. Inclusion criteria included clinical diagnosis of FEVR in patients referred to our clinic for evaluation of decreased vision. Patients were excluded if a diagnosis of FEVR could not be made. Clinical and angiographic findings. A total of 87 subjects met the inclusion criteria for this study. A broad spectrum of previously undescribed clinical and angiographic findings were associated with FEVR on wide-field angiography. These findings can be grossly divided into anatomic and functional changes. Anatomic changes include aberrant circumferential peripheral vessels, venous and arterial tortuosity, late-phase disc leakage, central and peripheral telangiectasias, capillary anomalies, and capillary agenesis. Functional changes include venous-venous shunting, delayed arteriovenous transit, and delayed or absent choroidal perfusion on fluorescein angiography. Familial exudative vitreoretinopathy has a wide range of unrecognized or under-recognized clinical and angiographic findings that are easily identified using wide-field fluorescein angiography. These novel findings have led to an update of the original FEVR classification scheme and more complete characterization of early stages of FEVR.
AbstractList To describe the diversity of clinical findings associated with familial exudative vitreoretinopathy (FEVR) using wide-field angiography and to update the current classification system. Retrospective case series at a single tertiary referral vitreoretinal practice. A total of 174 eyes of 87 subjects were studied. A retrospective chart review was conducted of patients with a diagnosis of FEVR between January 2011 and January 2013 at a single tertiary care retina practice. Data were collected from patient charts, including sex, gestational age at birth, age at presentation, referring diagnosis, family history, prior ocular surgery, clinical presentation, and diagnostic imaging in each eye. Inclusion criteria included clinical diagnosis of FEVR in patients referred to our clinic for evaluation of decreased vision. Patients were excluded if a diagnosis of FEVR could not be made. Clinical and angiographic findings. A total of 87 subjects met the inclusion criteria for this study. A broad spectrum of previously undescribed clinical and angiographic findings were associated with FEVR on wide-field angiography. These findings can be grossly divided into anatomic and functional changes. Anatomic changes include aberrant circumferential peripheral vessels, venous and arterial tortuosity, late-phase disc leakage, central and peripheral telangiectasias, capillary anomalies, and capillary agenesis. Functional changes include venous-venous shunting, delayed arteriovenous transit, and delayed or absent choroidal perfusion on fluorescein angiography. Familial exudative vitreoretinopathy has a wide range of unrecognized or under-recognized clinical and angiographic findings that are easily identified using wide-field fluorescein angiography. These novel findings have led to an update of the original FEVR classification scheme and more complete characterization of early stages of FEVR.
To describe the diversity of clinical findings associated with familial exudative vitreoretinopathy (FEVR) using wide-field angiography and to update the current classification system. Retrospective case series at a single tertiary referral vitreoretinal practice. A total of 174 eyes of 87 subjects were studied. A retrospective chart review was conducted of patients with a diagnosis of FEVR between January 2011 and January 2013 at a single tertiary care retina practice. Data were collected from patient charts, including sex, gestational age at birth, age at presentation, referring diagnosis, family history, prior ocular surgery, clinical presentation, and diagnostic imaging in each eye. Inclusion criteria included clinical diagnosis of FEVR in patients referred to our clinic for evaluation of decreased vision. Patients were excluded if a diagnosis of FEVR could not be made. Clinical and angiographic findings. A total of 87 subjects met the inclusion criteria for this study. A broad spectrum of previously undescribed clinical and angiographic findings were associated with FEVR on wide-field angiography. These findings can be grossly divided into anatomic and functional changes. Anatomic changes include aberrant circumferential peripheral vessels, venous and arterial tortuosity, late-phase disc leakage, central and peripheral telangiectasias, capillary anomalies, and capillary agenesis. Functional changes include venous-venous shunting, delayed arteriovenous transit, and delayed or absent choroidal perfusion on fluorescein angiography. Familial exudative vitreoretinopathy has a wide range of unrecognized or under-recognized clinical and angiographic findings that are easily identified using wide-field fluorescein angiography. These novel findings have led to an update of the original FEVR classification scheme and more complete characterization of early stages of FEVR.
To describe the diversity of clinical findings associated with familial exudative vitreoretinopathy (FEVR) using wide-field angiography and to update the current classification system.PURPOSETo describe the diversity of clinical findings associated with familial exudative vitreoretinopathy (FEVR) using wide-field angiography and to update the current classification system.Retrospective case series at a single tertiary referral vitreoretinal practice.DESIGNRetrospective case series at a single tertiary referral vitreoretinal practice.A total of 174 eyes of 87 subjects were studied.PARTICIPANTSA total of 174 eyes of 87 subjects were studied.A retrospective chart review was conducted of patients with a diagnosis of FEVR between January 2011 and January 2013 at a single tertiary care retina practice. Data were collected from patient charts, including sex, gestational age at birth, age at presentation, referring diagnosis, family history, prior ocular surgery, clinical presentation, and diagnostic imaging in each eye. Inclusion criteria included clinical diagnosis of FEVR in patients referred to our clinic for evaluation of decreased vision. Patients were excluded if a diagnosis of FEVR could not be made.METHODSA retrospective chart review was conducted of patients with a diagnosis of FEVR between January 2011 and January 2013 at a single tertiary care retina practice. Data were collected from patient charts, including sex, gestational age at birth, age at presentation, referring diagnosis, family history, prior ocular surgery, clinical presentation, and diagnostic imaging in each eye. Inclusion criteria included clinical diagnosis of FEVR in patients referred to our clinic for evaluation of decreased vision. Patients were excluded if a diagnosis of FEVR could not be made.Clinical and angiographic findings.MAIN OUTCOME MEASURESClinical and angiographic findings.A total of 87 subjects met the inclusion criteria for this study. A broad spectrum of previously undescribed clinical and angiographic findings were associated with FEVR on wide-field angiography. These findings can be grossly divided into anatomic and functional changes. Anatomic changes include aberrant circumferential peripheral vessels, venous and arterial tortuosity, late-phase disc leakage, central and peripheral telangiectasias, capillary anomalies, and capillary agenesis. Functional changes include venous-venous shunting, delayed arteriovenous transit, and delayed or absent choroidal perfusion on fluorescein angiography.RESULTSA total of 87 subjects met the inclusion criteria for this study. A broad spectrum of previously undescribed clinical and angiographic findings were associated with FEVR on wide-field angiography. These findings can be grossly divided into anatomic and functional changes. Anatomic changes include aberrant circumferential peripheral vessels, venous and arterial tortuosity, late-phase disc leakage, central and peripheral telangiectasias, capillary anomalies, and capillary agenesis. Functional changes include venous-venous shunting, delayed arteriovenous transit, and delayed or absent choroidal perfusion on fluorescein angiography.Familial exudative vitreoretinopathy has a wide range of unrecognized or under-recognized clinical and angiographic findings that are easily identified using wide-field fluorescein angiography. These novel findings have led to an update of the original FEVR classification scheme and more complete characterization of early stages of FEVR.CONCLUSIONSFamilial exudative vitreoretinopathy has a wide range of unrecognized or under-recognized clinical and angiographic findings that are easily identified using wide-field fluorescein angiography. These novel findings have led to an update of the original FEVR classification scheme and more complete characterization of early stages of FEVR.
Purpose To describe the diversity of clinical findings associated with familial exudative vitreoretinopathy (FEVR) using wide-field angiography and to update the current classification system. Design Retrospective case series at a single tertiary referral vitreoretinal practice. Participants A total of 174 eyes of 87 subjects were studied. Methods A retrospective chart review was conducted of patients with a diagnosis of FEVR between January 2011 and January 2013 at a single tertiary care retina practice. Data were collected from patient charts, including sex, gestational age at birth, age at presentation, referring diagnosis, family history, prior ocular surgery, clinical presentation, and diagnostic imaging in each eye. Inclusion criteria included clinical diagnosis of FEVR in patients referred to our clinic for evaluation of decreased vision. Patients were excluded if a diagnosis of FEVR could not be made. Main Outcome Measures Clinical and angiographic findings. Results A total of 87 subjects met the inclusion criteria for this study. A broad spectrum of previously undescribed clinical and angiographic findings were associated with FEVR on wide-field angiography. These findings can be grossly divided into anatomic and functional changes. Anatomic changes include aberrant circumferential peripheral vessels, venous and arterial tortuosity, late-phase disc leakage, central and peripheral telangiectasias, capillary anomalies, and capillary agenesis. Functional changes include venous-venous shunting, delayed arteriovenous transit, and delayed or absent choroidal perfusion on fluorescein angiography. Conclusions Familial exudative vitreoretinopathy has a wide range of unrecognized or under-recognized clinical and angiographic findings that are easily identified using wide-field fluorescein angiography. These novel findings have led to an update of the original FEVR classification scheme and more complete characterization of early stages of FEVR.
Author Trese, Michael T.
Drenser, Kimberly A.
Capone, Antonio
Kashani, Amir H.
Brown, Kevin T.
Chang, Emmanuel
Author_xml – sequence: 1
  givenname: Amir H.
  surname: Kashani
  fullname: Kashani, Amir H.
  organization: Department of Ophthalmology, University of Southern California, Los Angeles, California
– sequence: 2
  givenname: Kevin T.
  surname: Brown
  fullname: Brown, Kevin T.
  organization: School of Medicine, Wayne State University, Detroit, Michigan
– sequence: 3
  givenname: Emmanuel
  surname: Chang
  fullname: Chang, Emmanuel
  organization: Retina and Vitreous of Texas, Houston, Texas
– sequence: 4
  givenname: Kimberly A.
  surname: Drenser
  fullname: Drenser, Kimberly A.
  organization: Associated Retinal Consultants, P.C., Royal Oak, Michigan
– sequence: 5
  givenname: Antonio
  surname: Capone
  fullname: Capone, Antonio
  organization: Associated Retinal Consultants, P.C., Royal Oak, Michigan
– sequence: 6
  givenname: Michael T.
  surname: Trese
  fullname: Trese, Michael T.
  email: mgjt46@aol.com
  organization: Associated Retinal Consultants, P.C., Royal Oak, Michigan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25005911$$D View this record in MEDLINE/PubMed
BookMark eNqVkl1rFDEUhoNU7Lb6D0Tm0puZnmQymRkRodS2CoWKH8UbCZnsGTZrZrImmW3335thqxdCKV6FJM_7Bp6cI3IwuhEJeUmhoEDFybpwm1VcqYIB5QVUBbD2CVnQirc5r2l5QBYJo7ngDA7JUQhrABCi5M_IIasAqpbSBfnx3mzRBxN3meuzzxjNqGx2o4KerPLZ6egGZQ2GzIzZJxUNjjFktyausgs1GGsSfH43LdPNFrMbEz06P5e4jYqr3XPytFc24Iv79Zh8uzj_evYhv7q-_Hh2epVrXkPMGYWyr0WlVVlC3XS16LseBG9AM2hVVyHrNJSs6gVNB2nPG9qzhoFo-rLh5TF5ve_dePdrwhDlYIJGa9WIbgqSCta2gvO6Seire3TqBlzKjTeD8jv5R0kC-B7Q3oXgsf-LUJCzebmWe_NyNi-hksl8ir35J6ZNTFrcGL0y9rHwu30Yk6StQS-DTqo1Lo1HHeXSmf8t0NaMRiv7E3cY1m7y6V-TCBmYBPllnox5MCgH4G35PRW8fbjg8fd_Azpgyik
CitedBy_id crossref_primary_10_1097_IAE_0000000000002490
crossref_primary_10_1186_s12886_023_02884_7
crossref_primary_10_1038_s41572_024_00501_5
crossref_primary_10_1016_j_exer_2019_107720
crossref_primary_10_1186_s12886_023_03243_2
crossref_primary_10_3928_01913913_20210720_01
crossref_primary_10_1016_j_celrep_2017_06_004
crossref_primary_10_1155_2017_3080245
crossref_primary_10_1155_2020_7681926
crossref_primary_10_1371_journal_pone_0149176
crossref_primary_10_1177_2474126417705256
crossref_primary_10_3928_23258160_20240410_02
crossref_primary_10_4103_ijo_IJO_1403_20
crossref_primary_10_1167_iovs_66_2_9
crossref_primary_10_1167_tvst_12_3_16
crossref_primary_10_1038_srep30523
crossref_primary_10_1080_13816810_2016_1217551
crossref_primary_10_1177_2515841419899495
crossref_primary_10_1007_s00417_016_3415_x
crossref_primary_10_3109_13816810_2015_1120318
crossref_primary_10_1016_j_ophtha_2015_05_036
crossref_primary_10_1016_j_ophtha_2015_07_024
crossref_primary_10_1097_IIO_0000000000000336
crossref_primary_10_1002_jbm4_10741
crossref_primary_10_1167_iovs_64_13_27
crossref_primary_10_3928_23258160_20190503_11
crossref_primary_10_1371_journal_pone_0271326
crossref_primary_10_1167_iovs_63_4_7
crossref_primary_10_1016_j_exer_2022_108977
crossref_primary_10_3928_23258160_20201005_07
crossref_primary_10_1097_IAE_0000000000003122
crossref_primary_10_1016_j_oret_2025_02_018
crossref_primary_10_3928_23258160_20190401_01
crossref_primary_10_1097_IAE_0000000000000771
crossref_primary_10_1167_iovs_17_23541
crossref_primary_10_1016_j_ajo_2024_01_029
crossref_primary_10_1016_j_oret_2025_02_022
crossref_primary_10_1016_j_oret_2017_11_003
crossref_primary_10_3389_fped_2023_1252875
crossref_primary_10_1097_IJG_0000000000000810
crossref_primary_10_1186_s40942_018_0122_2
crossref_primary_10_1167_iovs_61_2_39
crossref_primary_10_1001_jamaophthalmol_2019_1484
crossref_primary_10_1016_j_survophthal_2021_01_011
crossref_primary_10_1001_jamaophthalmol_2019_1493
crossref_primary_10_1038_srep26564
crossref_primary_10_1136_bjophthalmol_2019_315598
crossref_primary_10_1136_bjophthalmol_2021_320084
crossref_primary_10_1177_24741264221129430
crossref_primary_10_1016_j_jcjo_2019_11_001
crossref_primary_10_1167_iovs_65_4_1
crossref_primary_10_22608_APO_201855
crossref_primary_10_4103_ijo_IJO_1917_20
crossref_primary_10_1371_journal_pone_0107048
crossref_primary_10_3390_genes14010212
crossref_primary_10_1097_IAE_0000000000000897
crossref_primary_10_1167_iovs_65_13_4
crossref_primary_10_3390_jcm10081767
crossref_primary_10_5301_ejo_5000639
crossref_primary_10_1097_IAE_0000000000000937
crossref_primary_10_1080_13816810_2020_1867756
crossref_primary_10_1080_13816810_2019_1686157
crossref_primary_10_1186_s12886_019_1128_8
crossref_primary_10_3390_genes12070980
crossref_primary_10_3928_23258160_20220316_04
crossref_primary_10_1080_13816810_2016_1253107
crossref_primary_10_1080_02713683_2020_1737715
crossref_primary_10_3928_23258160_20210302_07
crossref_primary_10_1080_08820538_2022_2085518
crossref_primary_10_1097_IAE_0000000000001912
crossref_primary_10_1080_02713683_2023_2213867
crossref_primary_10_1097_IIO_0000000000000260
crossref_primary_10_3928_01913913_20241122_01
crossref_primary_10_3928_23258160_20151214_02
crossref_primary_10_1016_j_exer_2023_109574
crossref_primary_10_1080_13816810_2020_1723118
crossref_primary_10_1097_IAE_0000000000004005
crossref_primary_10_1007_s00417_024_06668_7
crossref_primary_10_3928_01913913_20220228_01
crossref_primary_10_1038_eye_2015_240
crossref_primary_10_1109_ACCESS_2019_2961418
crossref_primary_10_3390_genes14030587
crossref_primary_10_3928_23258160_20210628_09
crossref_primary_10_1111_ceo_14494
crossref_primary_10_1097_IAE_0000000000003280
crossref_primary_10_1007_s10792_025_03461_1
crossref_primary_10_3928_23258160_20231020_01
crossref_primary_10_17816_rpoj112024
crossref_primary_10_3928_23258160_20220705_01
crossref_primary_10_1093_hmg_ddw041
crossref_primary_10_1016_j_ajo_2020_07_013
crossref_primary_10_1111_iwj_14611
crossref_primary_10_1016_j_ajoc_2023_101798
crossref_primary_10_1097_IAE_0000000000002623
crossref_primary_10_1007_s10384_017_0547_4
crossref_primary_10_1016_j_jaapos_2020_11_004
crossref_primary_10_3928_23258160_20180803_02
crossref_primary_10_4103_ijo_IJO_2292_21
crossref_primary_10_1155_2020_4212158
crossref_primary_10_21516_2072_0076_2023_16_3_19_25
crossref_primary_10_1097_ICB_0000000000001059
crossref_primary_10_1167_iovs_64_2_18
crossref_primary_10_1016_j_exer_2020_108165
crossref_primary_10_1002_mgg3_948
crossref_primary_10_1038_s41598_022_11455_7
crossref_primary_10_3928_23258160_20230609_01
crossref_primary_10_1016_j_preteyeres_2020_100938
crossref_primary_10_1080_13816810_2024_2427879
crossref_primary_10_1097_IAE_0000000000004147
crossref_primary_10_4274_tjo_galenos_2023_72609
crossref_primary_10_1186_s12920_022_01204_0
crossref_primary_10_1097_ICB_0000000000001322
crossref_primary_10_1167_iovs_62_15_4
crossref_primary_10_1089_crispr_2020_0009
Cites_doi 10.1001/archopht.1971.01000010152007
10.1016/j.ophtha.2013.08.010
10.1111/j.1399-0004.1993.tb03898.x
10.1016/S0002-9394(14)73977-7
10.1586/eop.12.26
10.1097/IAE.0b013e3181679bf6
10.1016/S0002-9394(14)74800-7
10.1002/humu.20191
10.1002/ajmg.1320450128
10.1016/j.ophtha.2011.06.020
10.1006/bbrc.1993.1666
10.1001/archopht.1985.01050020090029
10.1016/S0161-6420(84)34119-7
10.1016/S0161-6420(98)96002-X
10.1016/0002-9394(69)91237-9
10.1001/archopht.1976.03910040034006
10.1001/archopht.1981.03930021019006
10.1167/iovs.11-8629
ContentType Journal Article
Copyright 2014 American Academy of Ophthalmology
American Academy of Ophthalmology
Copyright © 2014 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2014 American Academy of Ophthalmology
– notice: American Academy of Ophthalmology
– notice: Copyright © 2014 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.ophtha.2014.05.029
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1549-4713
EndPage 2227
ExternalDocumentID 25005911
10_1016_j_ophtha_2014_05_029
S016164201400493X
1_s2_0_S016164201400493X
Genre Journal Article
GroupedDBID ---
--K
.1-
.55
.FO
.GJ
0R~
123
1B1
1CY
1P~
1~5
29N
4.4
457
4G.
53G
5RE
5VS
7-5
71M
AAEDT
AAEDW
AALRI
AAQFI
AAQQT
AAQXK
AAXUO
ABCQX
ABFRF
ABJNI
ABLJU
ABMAC
ABOCM
ABWVN
ACGFO
ACGFS
ACIUM
ACNCT
ACRPL
ACVFH
ADCNI
ADMUD
ADNMO
AEFWE
AENEX
AEUPX
AEVXI
AFFNX
AFJKZ
AFPUW
AFRHN
AFTJW
AGCQF
AGQPQ
AIGII
AITUG
AJUYK
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
BELOY
C5W
CS3
DU5
EBS
EFJIC
EFKBS
EJD
F5P
FDB
FEDTE
FGOYB
GBLVA
HVGLF
HZ~
IHE
J1W
K-O
KOM
L7B
M27
M41
MO0
N4W
N9A
NQ-
O9-
OF-
OPF
OQ~
P2P
R2-
ROL
RPZ
SDG
SEL
SES
SSZ
UHS
UNMZH
UV1
WH7
X7M
XH2
XPP
Z5R
ZGI
ZXP
ADPAM
RIG
AAIAV
AGZHU
AHPSJ
ALXNB
ZA5
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c470t-2103f765ca33078b76fbf06480c209ab5e2bc0325f61209b5e481f282068f3843
ISSN 0161-6420
1549-4713
IngestDate Thu Jul 10 19:16:45 EDT 2025
Mon Jul 21 06:04:19 EDT 2025
Thu Apr 24 23:03:07 EDT 2025
Tue Jul 01 03:37:57 EDT 2025
Fri Feb 23 02:22:15 EST 2024
Sun Feb 23 10:19:58 EST 2025
Tue Aug 26 16:37:04 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords FEVR
familial exudative vitreoretinopathy
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
Copyright © 2014 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c470t-2103f765ca33078b76fbf06480c209ab5e2bc0325f61209b5e481f282068f3843
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 25005911
PQID 1629964478
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_1629964478
pubmed_primary_25005911
crossref_primary_10_1016_j_ophtha_2014_05_029
crossref_citationtrail_10_1016_j_ophtha_2014_05_029
elsevier_sciencedirect_doi_10_1016_j_ophtha_2014_05_029
elsevier_clinicalkeyesjournals_1_s2_0_S016164201400493X
elsevier_clinicalkey_doi_10_1016_j_ophtha_2014_05_029
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-11-01
PublicationDateYYYYMMDD 2014-11-01
PublicationDate_xml – month: 11
  year: 2014
  text: 2014-11-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Ophthalmology (Rochester, Minn.)
PublicationTitleAlternate Ophthalmology
PublicationYear 2014
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Bergen, Glassman (bib8) 1983; 15
Ranchod, Ho, Drenser (bib9) 2011; 118
Pendergast, Trese (bib12) 1998; 105
Poulter, Davidson, Ali (bib20) 2012; 53
Miyakubo, Hashimoto, Miyakubo (bib3) 1984; 91
Shastry, Trese (bib15) 1993; 193
Li, Fuhrmann, Schwinger (bib17) 1992; 113
Kashani, Learned, Nudleman (bib13) 2014; 121
Shastry, Trese (bib16) 1993; 45
Criswick, Schepens (bib1) 1969; 68
Li, Muller, Fuhrmann (bib18) 1992; 51
Quiram, Drenser, Lai (bib11) 2008; 28
Shastry, Hartzer, Trese (bib14) 1993; 44
Trese, Kashani (bib21) 2012; 7
Boldrey, Egbert, Gass, Friberg (bib10) 1985; 103
Qin, Hayashi, Oshima (bib22) 2005; 26
Canny, Oliver (bib2) 1976; 94
Plager, Orgel, Ellis (bib19) 1992; 114
Brockhurst, Albert, Zakov (bib6) 1981; 99
Tasman, Augsburger, Shields (bib7) 1981; 79
Gow, Oliver (bib5) 1971; 86
Benson (bib4) 1995; 93
Shastry (10.1016/j.ophtha.2014.05.029_bib16) 1993; 45
Boldrey (10.1016/j.ophtha.2014.05.029_bib10) 1985; 103
Canny (10.1016/j.ophtha.2014.05.029_bib2) 1976; 94
Li (10.1016/j.ophtha.2014.05.029_bib17) 1992; 113
Qin (10.1016/j.ophtha.2014.05.029_bib22) 2005; 26
Miyakubo (10.1016/j.ophtha.2014.05.029_bib3) 1984; 91
Kashani (10.1016/j.ophtha.2014.05.029_bib13) 2014; 121
Trese (10.1016/j.ophtha.2014.05.029_bib21) 2012; 7
Ranchod (10.1016/j.ophtha.2014.05.029_bib9) 2011; 118
Shastry (10.1016/j.ophtha.2014.05.029_bib14) 1993; 44
Brockhurst (10.1016/j.ophtha.2014.05.029_bib6) 1981; 99
Shastry (10.1016/j.ophtha.2014.05.029_bib15) 1993; 193
Gow (10.1016/j.ophtha.2014.05.029_bib5) 1971; 86
Bergen (10.1016/j.ophtha.2014.05.029_bib8) 1983; 15
Quiram (10.1016/j.ophtha.2014.05.029_bib11) 2008; 28
Plager (10.1016/j.ophtha.2014.05.029_bib19) 1992; 114
Poulter (10.1016/j.ophtha.2014.05.029_bib20) 2012; 53
Tasman (10.1016/j.ophtha.2014.05.029_bib7) 1981; 79
Pendergast (10.1016/j.ophtha.2014.05.029_bib12) 1998; 105
Li (10.1016/j.ophtha.2014.05.029_bib18) 1992; 51
Benson (10.1016/j.ophtha.2014.05.029_bib4) 1995; 93
Criswick (10.1016/j.ophtha.2014.05.029_bib1) 1969; 68
References_xml – volume: 45
  start-page: 111
  year: 1993
  end-page: 113
  ident: bib16
  article-title: X-linked familial exudative vitreoretinopathy (FEVR): results of DNA analysis with candidate genes
  publication-title: Am J Med Genet
– volume: 26
  start-page: 104
  year: 2005
  end-page: 112
  ident: bib22
  article-title: Complexity of the genotype-phenotype correlation in familial exudative vitreoretinopathy with mutations in the
  publication-title: Hum Mutat
– volume: 44
  start-page: 275
  year: 1993
  end-page: 276
  ident: bib14
  article-title: Familial exudative vitreoretinopathy: multiple modes of inheritance
  publication-title: Clin Genet
– volume: 53
  start-page: 2873
  year: 2012
  end-page: 2879
  ident: bib20
  article-title: Recessive mutations in
  publication-title: Invest Ophthalmol Vis Sci
– volume: 94
  start-page: 1114
  year: 1976
  end-page: 1120
  ident: bib2
  article-title: Fluorescein angiographic findings in familial exudative vitreoretinopathy
  publication-title: Arch Ophthalmol
– volume: 114
  start-page: 145
  year: 1992
  end-page: 148
  ident: bib19
  article-title: X-linked recessive familial exudative vitreoretinopathy
  publication-title: Am J Ophthalmol
– volume: 68
  start-page: 578
  year: 1969
  end-page: 594
  ident: bib1
  article-title: Familial exudative vitreoretinopathy
  publication-title: Am J Ophthalmol
– volume: 51
  start-page: 749
  year: 1992
  end-page: 754
  ident: bib18
  article-title: The autosomal dominant familial exudative vitreoretinopathy locus maps on 11q and is closely linked to D11S533
  publication-title: Am J Hum Genet
– volume: 99
  start-page: 2143
  year: 1981
  end-page: 2146
  ident: bib6
  article-title: Pathologic findings in familial exudative vitreoretinopathy
  publication-title: Arch Ophthalmol
– volume: 103
  start-page: 238
  year: 1985
  end-page: 241
  ident: bib10
  article-title: The histopathology of familial exudative vitreoretinopathy: a report of two cases
  publication-title: Arch Ophthalmol
– volume: 93
  start-page: 473
  year: 1995
  end-page: 521
  ident: bib4
  article-title: Familial exudative vitreoretinopathy
  publication-title: Trans Am Ophthalmol Soc
– volume: 15
  start-page: 275
  year: 1983
  end-page: 276
  ident: bib8
  article-title: Familial exudative vitreoretinopathy
  publication-title: Ann Ophthalmol
– volume: 79
  start-page: 211
  year: 1981
  end-page: 226
  ident: bib7
  article-title: Familial exudative vitreoretinopathy
  publication-title: Trans Am Ophthalmol Soc
– volume: 91
  start-page: 1524
  year: 1984
  end-page: 1530
  ident: bib3
  article-title: Retinal vascular pattern in familial exudative vitreoretinopathy
  publication-title: Ophthalmology
– volume: 86
  start-page: 150
  year: 1971
  end-page: 155
  ident: bib5
  article-title: Familial exudative vitreoretinopathy: an expanded view
  publication-title: Arch Ophthalmol
– volume: 121
  start-page: 262
  year: 2014
  end-page: 268
  ident: bib13
  article-title: High prevalence of peripheral retinal vascular anomalies in family members of patients with familial exudative vitreoretinopathy
  publication-title: Ophthalmology
– volume: 193
  start-page: 599
  year: 1993
  end-page: 603
  ident: bib15
  article-title: Mapping studies of an X-linked familial exudative vitreoretinopathy
  publication-title: Biochem Biophys Res Commun
– volume: 7
  start-page: 281
  year: 2012
  end-page: 292
  ident: bib21
  article-title: Advances in the diagnosis, management and pathophysiology of capillary nonperfusion
  publication-title: Expert Rev Ophthalmol
– volume: 113
  start-page: 712
  year: 1992
  end-page: 713
  ident: bib17
  article-title: The gene for autosomal dominant familial exudative vitreoretinopathy (Criswick-Schepens) on the long arm of chromosome 11
  publication-title: Am J Ophthalmol
– volume: 118
  start-page: 2070
  year: 2011
  end-page: 2075
  ident: bib9
  article-title: Clinical presentation of familial exudative vitreoretinopathy
  publication-title: Ophthalmology
– volume: 28
  start-page: S8
  year: 2008
  end-page: 12
  ident: bib11
  article-title: Treatment of vascularly active familial exudative vitreoretinopathy with pegaptanib sodium (Macugen)
  publication-title: Retina
– volume: 105
  start-page: 1015
  year: 1998
  end-page: 1023
  ident: bib12
  article-title: Familial exudative vitreoretinopathy. Results of surgical management
  publication-title: Ophthalmology
– volume: 86
  start-page: 150
  year: 1971
  ident: 10.1016/j.ophtha.2014.05.029_bib5
  article-title: Familial exudative vitreoretinopathy: an expanded view
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.1971.01000010152007
– volume: 121
  start-page: 262
  year: 2014
  ident: 10.1016/j.ophtha.2014.05.029_bib13
  article-title: High prevalence of peripheral retinal vascular anomalies in family members of patients with familial exudative vitreoretinopathy
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2013.08.010
– volume: 15
  start-page: 275
  year: 1983
  ident: 10.1016/j.ophtha.2014.05.029_bib8
  article-title: Familial exudative vitreoretinopathy
  publication-title: Ann Ophthalmol
– volume: 44
  start-page: 275
  year: 1993
  ident: 10.1016/j.ophtha.2014.05.029_bib14
  article-title: Familial exudative vitreoretinopathy: multiple modes of inheritance
  publication-title: Clin Genet
  doi: 10.1111/j.1399-0004.1993.tb03898.x
– volume: 114
  start-page: 145
  year: 1992
  ident: 10.1016/j.ophtha.2014.05.029_bib19
  article-title: X-linked recessive familial exudative vitreoretinopathy
  publication-title: Am J Ophthalmol
  doi: 10.1016/S0002-9394(14)73977-7
– volume: 7
  start-page: 281
  year: 2012
  ident: 10.1016/j.ophtha.2014.05.029_bib21
  article-title: Advances in the diagnosis, management and pathophysiology of capillary nonperfusion
  publication-title: Expert Rev Ophthalmol
  doi: 10.1586/eop.12.26
– volume: 28
  start-page: S8
  issue: Suppl
  year: 2008
  ident: 10.1016/j.ophtha.2014.05.029_bib11
  article-title: Treatment of vascularly active familial exudative vitreoretinopathy with pegaptanib sodium (Macugen)
  publication-title: Retina
  doi: 10.1097/IAE.0b013e3181679bf6
– volume: 79
  start-page: 211
  year: 1981
  ident: 10.1016/j.ophtha.2014.05.029_bib7
  article-title: Familial exudative vitreoretinopathy
  publication-title: Trans Am Ophthalmol Soc
– volume: 113
  start-page: 712
  year: 1992
  ident: 10.1016/j.ophtha.2014.05.029_bib17
  article-title: The gene for autosomal dominant familial exudative vitreoretinopathy (Criswick-Schepens) on the long arm of chromosome 11
  publication-title: Am J Ophthalmol
  doi: 10.1016/S0002-9394(14)74800-7
– volume: 26
  start-page: 104
  year: 2005
  ident: 10.1016/j.ophtha.2014.05.029_bib22
  article-title: Complexity of the genotype-phenotype correlation in familial exudative vitreoretinopathy with mutations in the LRP5 and/or FZD4 genes
  publication-title: Hum Mutat
  doi: 10.1002/humu.20191
– volume: 45
  start-page: 111
  year: 1993
  ident: 10.1016/j.ophtha.2014.05.029_bib16
  article-title: X-linked familial exudative vitreoretinopathy (FEVR): results of DNA analysis with candidate genes
  publication-title: Am J Med Genet
  doi: 10.1002/ajmg.1320450128
– volume: 118
  start-page: 2070
  year: 2011
  ident: 10.1016/j.ophtha.2014.05.029_bib9
  article-title: Clinical presentation of familial exudative vitreoretinopathy
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2011.06.020
– volume: 193
  start-page: 599
  year: 1993
  ident: 10.1016/j.ophtha.2014.05.029_bib15
  article-title: Mapping studies of an X-linked familial exudative vitreoretinopathy
  publication-title: Biochem Biophys Res Commun
  doi: 10.1006/bbrc.1993.1666
– volume: 51
  start-page: 749
  year: 1992
  ident: 10.1016/j.ophtha.2014.05.029_bib18
  article-title: The autosomal dominant familial exudative vitreoretinopathy locus maps on 11q and is closely linked to D11S533
  publication-title: Am J Hum Genet
– volume: 103
  start-page: 238
  year: 1985
  ident: 10.1016/j.ophtha.2014.05.029_bib10
  article-title: The histopathology of familial exudative vitreoretinopathy: a report of two cases
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.1985.01050020090029
– volume: 91
  start-page: 1524
  year: 1984
  ident: 10.1016/j.ophtha.2014.05.029_bib3
  article-title: Retinal vascular pattern in familial exudative vitreoretinopathy
  publication-title: Ophthalmology
  doi: 10.1016/S0161-6420(84)34119-7
– volume: 105
  start-page: 1015
  year: 1998
  ident: 10.1016/j.ophtha.2014.05.029_bib12
  article-title: Familial exudative vitreoretinopathy. Results of surgical management
  publication-title: Ophthalmology
  doi: 10.1016/S0161-6420(98)96002-X
– volume: 68
  start-page: 578
  year: 1969
  ident: 10.1016/j.ophtha.2014.05.029_bib1
  article-title: Familial exudative vitreoretinopathy
  publication-title: Am J Ophthalmol
  doi: 10.1016/0002-9394(69)91237-9
– volume: 93
  start-page: 473
  year: 1995
  ident: 10.1016/j.ophtha.2014.05.029_bib4
  article-title: Familial exudative vitreoretinopathy
  publication-title: Trans Am Ophthalmol Soc
– volume: 94
  start-page: 1114
  year: 1976
  ident: 10.1016/j.ophtha.2014.05.029_bib2
  article-title: Fluorescein angiographic findings in familial exudative vitreoretinopathy
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.1976.03910040034006
– volume: 99
  start-page: 2143
  year: 1981
  ident: 10.1016/j.ophtha.2014.05.029_bib6
  article-title: Pathologic findings in familial exudative vitreoretinopathy
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.1981.03930021019006
– volume: 53
  start-page: 2873
  year: 2012
  ident: 10.1016/j.ophtha.2014.05.029_bib20
  article-title: Recessive mutations in TSPAN12 cause retinal dysplasia and severe familial exudative vitreoretinopathy (FEVR)
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.11-8629
SSID ssj0006634
Score 2.5108182
Snippet To describe the diversity of clinical findings associated with familial exudative vitreoretinopathy (FEVR) using wide-field angiography and to update the...
Purpose To describe the diversity of clinical findings associated with familial exudative vitreoretinopathy (FEVR) using wide-field angiography and to update...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2220
SubjectTerms Adolescent
Adult
Child
Child, Preschool
Female
Fluorescein Angiography
Humans
Infant
Infant, Newborn
Male
Middle Aged
Ophthalmology
Optic Disk - blood supply
Retinal Artery - pathology
Retinal Diseases - classification
Retinal Diseases - diagnosis
Retinal Hemorrhage - diagnosis
Retinal Telangiectasis - diagnosis
Retinal Vein - pathology
Retrospective Studies
Title Diversity of Retinal Vascular Anomalies in Patients with Familial Exudative Vitreoretinopathy
URI https://www.clinicalkey.com/#!/content/1-s2.0-S016164201400493X
https://www.clinicalkey.es/playcontent/1-s2.0-S016164201400493X
https://dx.doi.org/10.1016/j.ophtha.2014.05.029
https://www.ncbi.nlm.nih.gov/pubmed/25005911
https://www.proquest.com/docview/1629964478
Volume 121
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZZCmMvY_dlNzTYW3CwJd_yGNqMsNANurTLyxCSIxGXxCmJA9v-xf7xjizJdUhKu76Y2LEs-ZxP0jnH54LQpzQkmeIz4hHJ-17ISez144h6GY1g7gk5i5S2Q55-jUfn4ZdpNG21_ja8lral6GV_DsaV3IercA34qqNk_4Oz9UPhAvwG_sIROAzHO_H4pOlUcaaDl4HgF863FDT7JUjZlceVTsWfXwezVeUutK18-Gs7M6m_L_JybWIai5UuU7zzuffb1byc88XSJGyqrA620JZxvS-KXsOkMOabuSkV1R0s83V31NtT-sewHxfdSf3HsbNbD5dLXmxl7fdxsgY92zp-5Lp4yeJ3d9Br2iqC0Abt1QY0F0Sz4-OphU4P1CB_Z1E2cdMOfUFzjSX2VulOk4N7gTFLXPZWFYm0F19YJWm15NjNsv1dj0IPItCLWp9OH6AjApoHaaOjwfjsx7je3kFEswnjzahdPGblNLjf103yzk36TCXXTJ6gx1YhwQODrqeoJYtn6OGpdbl4jn7WIMMrhS3IsAMZrkGG8wI7kGENMuxAhmuQ4T2QvUDnn4eT45Fna3J4WZj4pUcCn6okjjJOYXdIRRIroUCsTf2M-H0uIklE5lMSqVhHZcN5mAaK6CoBqaJpSF-idrEq5GuEeZzMRMSzgCpQ01OVQlsikoDLfiqooB1EHeVYZhPW67opC-Y8Ey-ZoTfT9GZ-xIDeHeTVra5MwpZb7o8cU5gLRobtkwGKbmmXHGonN3Z92LCAbQjz2R6ymi2tmGvE1zv0-dGhhsEuoD_t8UKuttBXDGIlqDZJ2kGvDJzqtwclB3SoIHhzzzd9ix5dz-V3qF2ut_I9SOKl-GDnxj9T5t7P
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diversity+of+Retinal+Vascular+Anomalies+in+Patients+with+Familial+Exudative+Vitreoretinopathy&rft.jtitle=Ophthalmology+%28Rochester%2C+Minn.%29&rft.au=Kashani%2C+Amir+H.&rft.au=Brown%2C+Kevin+T.&rft.au=Chang%2C+Emmanuel&rft.au=Drenser%2C+Kimberly+A.&rft.date=2014-11-01&rft.pub=Elsevier+Inc&rft.issn=0161-6420&rft.volume=121&rft.issue=11&rft.spage=2220&rft.epage=2227&rft_id=info:doi/10.1016%2Fj.ophtha.2014.05.029&rft.externalDocID=S016164201400493X
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F01616420%2FS0161642013X00223%2Fcov150h.gif